This report provides a comprehensive analysis of AstraZeneca's business strategies, resources, and sustainability initiatives. It begins with an introduction to the business environment and the pharmaceutical industry's challenges, particularly during the COVID-19 pandemic. The report then identifies AstraZeneca's key business strategies over the past five years, including its marketing mix (product, price, place, promotion) and adaptations in response to the pandemic. It further examines the company's resources and capabilities using VRIO and SWOT analyses to assess its competitive advantages and weaknesses. The report also evaluates how AstraZeneca can implement environmental sustainability science, theories, and practices to enhance its competitiveness, focusing on areas like access to health, environmental protection, and ethical practices. Finally, the report concludes with a summary of the findings and recommendations for future strategies.
![[object Object]](/_next/static/media/star-bottom.7253800d.svg)
